Labor pain
Conditions
Interventions
Group RD:Group RD received 0.1% ropivacaine plus 0.5 µg/ml dexmedetomidine epidurally
Group RS:Group RS received 0.1% ropivacaine plus 0.5 µg/ml sufentanil epidurally
Group RDS:Group RDS received 0.1% ropivacaine plus 0.25 µg/ml dexmedetomidine and 0.25 µg/ml sufentanil epidurally
Group C:Intrathecal drug injection: 1 ml sodium (0.9%) , then combined with an epidural of 0.1% ropivacaine+0.2 µg/ml sulfentanil
Group D:GroupD were injected with 5 µg dexmedetomidine intrathecally, then combined with an epidural of 0.1% ropivacaine+0.2 µg/ml sulfentanil
Group S:Group S were injected with 5 µg sufentanil intrathecally, then combined with an epidural of 0.1% ropivacaine+0.2 µg/ml sulfentanil
Sponsors
Anesthesiology Department, Shenzhen Maternal and Child Health Care Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women who are expected to undergo vaginal delivery during the period of 35 to 42 weeks; ASA I - II
Exclusion criteria
Exclusion criteria: Coagulant function abnormality or there are other contraindications of intra-spinal anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| the onset time;the duration of each labor stage;Apgar score;the mode of delivery;the bolus times, total volume of anesthetic solution;the motor blockade level;the side effects; | — |
Countries
China
Contacts
Public ContactGehui Li
Anesthesiology Department, Shenzhen Maternal and Child Health Care Hospital
Outcome results
None listed